Produse farmaceutice
Information about customer
Title
CENTRUL PENTRU ACHIZITII PUBLICE CENTRALIZATE IN SANATATE
IDNO
1016601000212
Address
MOLDOVA,
locality,
MD-2009, Republica Moldova, Chişinău str. Cosmescu 3,
MD-2009
The contact person
Macari Doina,
doina.macari@capcs.md
Purchase data
ID
ocds-b3wdp1-MD-1663065889249
Title
Produse farmaceutice
Note
CPV Code
33600000-6 - Produse farmaceutice
Rationale
List of funding sources
Funding source cost
130954.13 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1663065889249-FS-1663065890070
IBAN
MD68TRPCCC518430A01859AA
Funding source cost
130954.13 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1663065889249-FS-1663065889935
IBAN
MD68TRPCCC518430A01859AA
Funding source cost
130954.13 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1663065889249-FS-1667813936778
IBAN
None
Funding source cost
130954.13 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1663065889249-FS-1668163507612
IBAN
None
Funding source cost
130954.13 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1663065889249-FS-1667813936663
IBAN
MD68TRPCCC518430A01859AA
Funding source cost
130954.13 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1663065889249-FS-1668163507431
IBAN
MD68TRPCCC518430A01859AA
Funding source cost
130954.13 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1663065889249-FS-1670336012264
IBAN
None
Funding source cost
130954.13 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1663065889249-FS-1670336012793
IBAN
None
Funding source cost
130954.13 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1663065889249-FS-1670336012614
IBAN
None
Funding source cost
130954.13 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1663065889249-FS-1670336012437
IBAN
None
Funding source cost
130954.13 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1663065889249-FS-1670336012074
IBAN
None
Funding source cost
130954.13 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1663065889249-FS-1670336011950
IBAN
MD68TRPCCC518430A01859AA
Funding source cost
130954.13 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1663065889249-FS-1670480971164
IBAN
None
Funding source cost
130954.13 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1663065889249-FS-1670480970930
IBAN
None
Funding source cost
130954.13 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1663065889249-FS-1670480970469
IBAN
MD68TRPCCC518430A01859AA
Funding source cost
130954.13 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1663065889249-FS-1670480971410
IBAN
None
Funding source cost
130954.13 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1663065889249-FS-1670480970677
IBAN
None
Funding source cost
130954.13 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1663065889249-FS-1670480971634
IBAN
None
Status Planning
Start the procedure:
1 Jan 2023
1 Jan 2024
Date of publication: 13 Sep 2022 13:45
Date of last modifications: 20 Dec 2022 18:35